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We report a simple technique for the high throughput generation 
of tissue spheroids based on encapsulation of dispersed adherent 
cells in particle-stabilised water-in-water emulsions. We 
demonstrate the cell encapsulation and spheroid generation using 
fibroblast cells which can find applications in 3D culturing, tissue 
engineering, inks for bioprinting and cell therapy. 
Recently, we have seen a great progress in 3D cell culture 
technologies and culture systems used for landmark 
developments in organoids with realistic microstructure,1 tissue 
engineering and simulating organ level physiology.2 The cells 
can form mini tissues or tissue spheroids in the form of a 3D cell 
culture model.3-5 Cell spheroids has been actively used for 
production of 3D tumour models6-8 and tissue reconstruction or 
organ bioprinting.5,9  Spheroids of adherent cells can be formed 
using different processes for cell clustering where they adhere 
to each other rather than to a substrate. The current processes 
of cell spheroid production involve spinner culture, NASA rotary 
culture and non-adhesive surfaces.10 In order to control the size 
of individual spheroids, the hanging-drop culture11,12 and 3D 
culturing in microwells13 are extensively used. Alternative 
techniques are based on micro-rotational flow14 and on the 
magneto-Archimedes effect15 to form similarly sized tissue 
spheroids.  
In the hanging drop method, small pendant drops of cell culture 
are hung from the underside of a culture dish lid, held in their 
position by surface tension forces. The cells concentrate at the 
bottom of the drops due to the gravity and adhere to each 
other, which results in the formation of the spheroids.16-18 The 
same method was also used to make spheroid assemblies 
containing different cell types.19,20 Bio-inks based on viable and 
similarly sized cell spheroids allow them to be bio-printed into 
3D structures and organs where they can proliferate and grow 
more efficiently than single cels.21 
 
Figure 1 Schematic of the preparation of tissue spheroids by encapsulation of adherent 
cells in a dextran-PEO water-in-water emulsion template stabilised by protein particles. 
Upon emulsification, cells prefer the discontinuous dextran phase which allow their 
encapsulation. Adding more concentrated PEO phase causes osmotic shrinking of the 
cell-rich dextran drops, whose interfacial tension packs the cells into tissue spheroids. 
The latter are isolated by breaking the emulsion by dilution with culture media.   
 
However, most of the current processes for generation of cell 
spheroids cannot be used for tissue engineering on a large scale. 
A new cheap and rapid technology is needed, capable of high 
throughput spheroid production. The current methods of 
production of cellosomes22,23 can serve as a possible way for 
larger scale production of desired spheroids. Encapsulation of 
cells in such structures has also been achieved by using natural 
biopolymers like alginate, pectin, agarose and chitosan.24  
 
a. School of Mathematics and Physical Sciences (Chemistry), University of Hull, 
Cottingham Road, Hull, HU67RX, UK. 
 *Corresponding author: V.N.Paunov@hull.ac.uk, Tel: +44 (0)1482 465660. 
♣Electronic Supplementary Information (ESI) available: See 
DOI: 10.1039/x0xx00000x 
COMMUNICATION Materials Horizons 
2 | Mater. Horiz., 2017, 00, 1-3 This journal is © The Royal Society of Chemistry 2017 
 
 
 
 
Figure 2 Optical and fluorescence microscope images of (a), (b) FITC labelled DEX droplets in PEO continuous phase stabilised using protein particles (β-lactoglobulin) and (c), (d) FDA 
stained yeast cells encapsulated in the same emulsion system. (e) and (f) show a similar system with higher cell concentration in the DEX drops. All scale bars are 50 µm in size. 
 
Here we report for the first time a rapid and scalable production 
technique of tissue spheroids by trapping cells in droplets of 
water-in water Pickering emulsion stabilised by protein 
particles. The emulsion is formed of an aqueous solution of 
dextran (DEX) dispersed in a continuous phase of aqueous 
solution of polyethylene oxide (PEO). The schematic of our cell 
spheroids fabrication method is shown in Figure 1 for adherent 
cells which are dispersed in the DEX phase. The formation of a 
stable DEX/PEO emulsion leads to the cells encapsulation in the 
DEX droplets. Further addition of more concentrated PEO phase 
leads to osmotic shrinking of the DEX drops and compression of 
the adherent cells in spheroids. Finally, the latter are isolated by 
breaking the DEX/PEO emulsion by dilution with culture media. 
This cheap and robust technique is easy to upscale and allows 
rapid preparation of similarly sized cell spheroids.  
Water-in-water emulsions have been stabilised effectively by 
the addition of solid particles.25,29 Nguyen et al.25 used β-
lactoglobulin particles (0.6 wt %) to stabilise DEX/PEO emulsion. 
We used similar emulsions25 stabilised with protein particles (β-
lactoglobulin or whey protein) as templates in our method for 
preparation of cell spheroids. The protein particles were always 
introduced into the PEO phase. The emulsion drops typically 
consisted of a DEX phase containing 2.0-5.5 wt % dextran (M.W. 
500kDa, Fisher Scientific, UK) stained with a 50 µl solution of 
1×10-5 M FITC dextran (M.W. 500 kDa Sigma Aldrich, UK). The 
DEX phase was added to the 4 wt% PEO (M.W. 200 kDa, Sigma 
Aldrich, UK) slowly over the course of one minute, while 
homogenising at 9000 rpm for additional 10 minutes using an 
IKA T25 Ultra Turrax. The detailed protocol for making the 
protein particles can be found in the ESI♣. 
Here we demonstrate the above protocol for producing stable 
DEX droplets in the PEO continuous phase, as evident from 
Figures 2a and 2b. Further, as a proof of principle, we prepared 
similar DEX/PEO emulsions with added 0.5 wt% hydrated yeast 
cells dispersed in the DEX phase. We found that cells prefer to 
accumulate in the sugar containing (DEX) phase rather than in 
the PEO phase. This phenomenon enabled us to trap the cells in 
the DEX drops dispersed in PEO phase as shown in Figures 2c 
and 2d. The viability of the cells was monitored by fluorescein 
diacetate (FDA) live/dead cell assay using a BX-51 fluorescence 
microscope equipped with a DP70 digital camera. FDA is a non-
fluorescent compound which easily diffuses through the cell 
membranes.26,27 The uptake and hydrolysis of the non-
fluorescent FDA by intracellular esterase leads to accumulation 
of a fluorescein within the cells if the cell membrane is intact.28 
In the present work, we used yeast to demonstrate the cell 
encapsulation and their selective packing in the DEX phase as 
the individual yeast cells are easier to distinguish in the DEX 
drops than fibroblasts. Figures 2e and 2f show the packing of a 
of higher concentration yeast cells in similar volume fraction of 
DEX phase. Similar result was obtained by adding more 
concentrated PEO phase to the pre-formed DEX/PEO emulsion 
which shrinks the DEX drops with the entrapped cells. 
Here we also demonstrate the generation of tissue spheroids 
from adherent fibroblast cells. We used human embryonic 
kidney cells (HEK293) which were cultured in media that 
contains 10% Fetal bovine serum (FBS) and PenStrep. 
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Figure 3 Optical microscopic image of (a) HEK 293 cells encapsulated in the dextran 
droplets in PEO continuous phase stabilised using protein particles (whey protein isolate) 
and (b) HEK 293 spheroids isolated from the emulsion formulation after increasing the 
concentration of the PEO continuous phase to 8% (W/V). All scale bars are 50 µm in size.  
The emulsion was prepared with the HEK293 cells dispersed in 
5.5 wt% dextran aqueous phase in a continuous phase of 4 wt% 
PEO. Both the DEX and the PEO phase were made with DMEM 
media. The particles used for stabilising the DEX/PEO emulsion 
were produced using whey protein isolate (see ESI for more 
details) and were mixed with the PEO phase. To avoid damaging 
the HEK293 cells by extensive shear the homogenisation was 
done using a syringe with 21 mm gauge and 0.8 mm internal 
needle diameter) with typically 10 pumps. The same volume 
fractions of HEK293 cells and the original DEX phase were mixed 
together prior to its dispersing into the PEO phase. We found 
that the HEK 293 cells also preferred the DEX phase (similar to 
the yeast) compared to the PEO phase. Figure 3a shows the 
fibroblast cells successfully encapsulated in the DEX droplets. 
Subsequently, in order to force the fibroblast cells trapped in 
the DEX drops to stick together, the PEO concentration in the 
continuous phase was increased by several fold dilution with 
more concentrated PEO solution in DMEM media. This resulted 
in an efflux of water from the DEX phase into the PEO phase as 
illustrated in Figure 1. Consequently, this led to the formation 
of tightly packed HEK293 spheroids as evident from Figure 3b. 
This was also observed at low and high magnification 
microscope images HEK 293 spheroids, as shown in Figure 4a 
and 4b. The detailed protocol for the spheroid generation and 
the cell viability studies are described in the ESI. 
The spheroids were separated by the process of gravitational 
sedimentation where the large spheroids sediments faster 
compared to single cells and the supernatant phase was 
extracted carefully leaving the spheroids at the bottom of the 
sample vials. The preservation of the cell viability in the 
spheroids is a critical issue during the whole emulsification and 
encapsulation process. We applied the FDA assay to the HEK293 
cell spheroids after they have been isolated from the DEX/PEO 
emulsion. Figure 4c and 4d compare the brightfield and 
fluorescence microscopy images of the treated HEK293 cell 
spheroids. One can see that the cells in the spheroids were 
highly active and viable which would enable them to have 
efficient cell growth and proliferation in various tissue 
engineering application. The scanning electron microscope 
(SEM) image in Figure 4e and 4f shows the arrangement of 
individual HEK293 cells in the spheroid. Fibroids cell 
proliferation depends crucially on the availability of 
neighbouring adherent cells or a solid substrate for their 
attachment. Generally, individual adherent cells, separated 
from substrate and neighbours do not proliferate as efficiently 
as the same cells clustered in aggregates.  
In summary, we have devised a general and effective strategy 
for preparation of cell spheroids by encapsulating cells in the 
dispersed phase of a water-in-water Pickering emulsion. We 
demonstrate the technique with S. Cerevisiae (yeast) and 
Human embryonic kidney cells (HEK293) for the purpose of 
spheroid generation. Aqueous dextran solution was used as the 
dispersed phase in a continuous PEO aqueous phase stabilised 
using protein particles made from β-lactoglobulin or whey 
protein isolate for yeast and HEK 293 cells, respectively. The cell 
spheroids can produced of different sizes dependent on the cell 
concentration in the emulsion. The method can be further 
modified by maintaining a monodisperse emulsion system to 
produce spheroids of uniform size, although this may not be a 
critically needed for tissue engineering applications. It is also 
worth mentioning that this current method of spheroid 
generation is not restricted to yeast or HEK 293 cells but also 
can be applied to other kind of adherent cell cultures, for 
example tumour cells for generating suitable tumour models. 
This will be reported in a follow up paper. We also envisage that 
this method can be extended to fabricate tissue spheroids for 
cell therapies and bio-ink formulations for 3D organ printing. 
This would be made possible by the high throughput generation 
of cell spheroids generated using the proposed method.  
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Figure 4 Optical microscopic image of (a) Low magnification HEK293 spheroids, (b) High magnification HEK293 spheroids, (c) and (d) Optical and florescence microscope images of 
HEK293 cell spheroids isolated from the DEX/PEO emulsion, showing the viability of the fibroblast cells by using FDA live/dead assay. (e) Scanning electron microscopic image of a 
HEK293 spheroid isolated from the emulsion formulation.    
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